Precigen Share Price Today
(NASDAQ: PGEN)

Name: Precigen Share Price Today (NASDAQ: PGEN) - Precigen Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Precigen share price is $1.33 & ₹115.84 as on 5 Feb 2025, 2.30 'hrs' IST

$1.33

▲

0.03

(2.31%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Precigen share price in Dollar and Rupees. Guide to invest in Precigen stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Precigen, along with analyst recommendations, forecasts, and comprehensive financials.

Precigen share price movements

Today's Low: $1.29
Today's High: $1.36
$1.33
3.01%
Downside
Day's Volatility :4.8%
Upside
1.85%
52 Weeks Low: $0.65
52 Weeks High: $1.93
$1.33
51.03%
Downside
52 Weeks Volatility :66.25%
Upside
31.09%

Precigen (PGEN) Returns

Period	Precigen Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	45.24%	0.5%	0.0%
6 Months	10.17%	-2.3%	0.0%
1 Year	-9.09%	3.8%	0.0%
3 Years	-41.7%	11.4%	-11.7%

Precigen (PGEN) Key Statistics

in dollars & INR

Previous Close	$1.3
Open	$1.29
Today's High	$1.355
Today's Low	$1.29
Market Capitalization	$395.4M
Today's Volume	$1.5M
52 Week High	$1.93
52 Week Low	$0.6513
Revenue TTM	$4.4M
EBITDA	$-88.6M
Earnings Per Share (EPS)	$-0.54
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-129.32%

How to invest in Precigen Stock (PGEN) from India?

It is very easy for Indian residents to invest directly in Precigen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Precigen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Precigen or PGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Precigen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Precigen shares which would translate to 0.655 fractional shares of Precigen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Precigen, in just a few clicks!

Returns in Precigen (PGEN) for Indian investors in Rupees

The Precigen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Precigen investment value today

Current value as on today

₹97,872

Returns

₹2,128

(-2.13%)

Returns from Precigen Stock

₹6,993 (-6.99%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Precigen (PGEN)

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Precigen Stock from India on INDmoney has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Precigen

Patients Capital Management LLC
6.12%
Adage Capital Partners Gp LLC
3.71%
BlackRock Inc
3.54%
Vanguard Group Inc
2.84%
Iridian Asset Management LLC
1.79%
Geode Capital Management, LLC
1.11%

Analyst Recommendation on Precigen

Buy

81%Buy

9%Hold

9%Sell

Based on 11 Wall street analysts offering stock ratings for Precigen(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Precigen Stock (PGEN)

What analysts predicted

Upside of 351.13%

Target:

$6.00

Current:

$1.33

Insights on Precigen Stock (Ticker Symbol: PGEN)

Price Movement
In the last 3 months, PGEN stock has moved up by 59.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 717.0K → 953.0K (in $), with an average increase of 24.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -58.79M → -23.97M (in $), with an average increase of 145.2% per quarter
PGEN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 65.1%
PGEN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 130.8%
Price to Sales
ForPGEN every $1 of sales, investors are willing to pay $72.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

PGEN Precigen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$160.6M	↓ 30.48%
Net Income	$-509.3M	↑ 335.26%
Net Profit Margin	-317.2%	↓ 266.54%

	FY19	Y/Y Change
Revenue	$90.7M	↓ 43.5%
Net Income	$-207.8M	↓ 59.21%
Net Profit Margin	-229.0%	↑ 88.2%

	FY20	Y/Y Change
Revenue	$103.2M	↑ 13.73%
Net Income	$-103.8M	↓ 50.05%
Net Profit Margin	-100.58%	↑ 128.42%

	FY21	Y/Y Change
Revenue	$103.9M	↑ 0.67%
Net Income	$-96.8M	↓ 6.75%
Net Profit Margin	-93.16%	↑ 7.42%

	FY22	Y/Y Change
Revenue	$26.9M	↓ 74.09%
Net Income	$-79.8M	↓ 17.56%
Net Profit Margin	-296.47%	↓ 203.31%

	FY23	Y/Y Change
Revenue	$6.2M	↓ 76.87%
Net Income	$-95.9M	↑ 20.22%
Net Profit Margin	-1.5K%	↓ 1244.16%

	Q2 FY23	Q/Q Change
Revenue	$1.8M	↓ 4.54%
Net Income	$-20.3M	↓ 10.62%
Net Profit Margin	-1.1K%	↑ 78.28%

	Q3 FY23	Q/Q Change
Revenue	$16.7M	↑ 846.35%
Net Income	$87.4M	↓ 530.04%
Net Profit Margin	522.54%	↑ 1672.46%

	Q4 FY23	Q/Q Change
Revenue	$1.2M	↓ 92.66%
Net Income	$-33.1M	↓ 137.83%
Net Profit Margin	-2.7K%	↓ 3214.4%

	Q1 FY24	Q/Q Change
Revenue	$1.1M	↓ 13.27%
Net Income	$-23.7M	↓ 28.19%
Net Profit Margin	-2.2K%	↑ 462.94%

	Q2 FY24	Q/Q Change
Revenue	$717.0K	↓ 32.68%
Net Income	$-58.8M	↑ 147.67%
Net Profit Margin	-8.2K%	↓ 5970.8%

	Q3 FY24	Q/Q Change
Revenue	$953.0K	↑ 32.91%
Net Income	$-24.0M	↓ 59.22%
Net Profit Margin	-2.5K%	↑ 5683.67%

	FY18	Y/Y Change
Profit	$97.3M	↓ 42.16%

	FY19	Y/Y Change
Profit	$29.3M	↓ 69.86%

	FY20	Y/Y Change
Profit	$47.7M	↑ 62.56%

	FY21	Y/Y Change
Profit	$45.5M	↓ 4.57%

	FY22	Y/Y Change
Profit	$20.6M	↓ 54.78%

	FY23	Y/Y Change
Profit	$106.0K	↓ 99.48%

	Q2 FY23	Q/Q Change
Profit	$70.0K	↓ 78.4%

	Q3 FY23	Q/Q Change
Profit	$15.2M	↑ 21592.86%

	Q4 FY23	Q/Q Change
Profit	$-1.3M	↓ 108.82%

	Q1 FY24	Q/Q Change
Profit	$-810.5K	↓ 39.47%

	Q2 FY24	Q/Q Change
Profit	$-297.0K	↓ 63.36%

	Q3 FY24	Q/Q Change
Profit	$-56.0K	↓ 81.14%

	FY18	Y/Y Change
Operating Cash Flow	$-124.2M	↑ 19.3%
Investing Cash Flow	$-151.2M	↓ 244.93%
Financing Cash Flow	$309.8M	↑ 7131.44%

	FY19	Y/Y Change
Operating Cash Flow	$-135.9M	↑ 9.41%
Investing Cash Flow	$86.9M	↓ 157.44%
Financing Cash Flow	$8.1M	↓ 97.37%

	FY20	Y/Y Change
Operating Cash Flow	$-77.0M	↓ 43.34%
Investing Cash Flow	$27.8M	↓ 68.02%
Financing Cash Flow	$32.7M	↑ 301.88%

	FY21	Y/Y Change
Operating Cash Flow	$-55.8M	↓ 27.59%
Investing Cash Flow	$-74.5M	↓ 368.33%
Financing Cash Flow	$121.2M	↑ 270.55%

	FY22	Y/Y Change
Operating Cash Flow	$-65.0M	↑ 16.63%
Investing Cash Flow	$226.4M	↓ 403.75%
Financing Cash Flow	$-155.3M	↓ 228.14%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-15.8M	↓ 14.25%
Investing Cash Flow	$23.5M	↓ 146.63%
Financing Cash Flow	$-14.6M	↓ 133.02%

Precigen Technicals Summary

Sell

Neutral

Buy

Precigen is currently in a neutral trading position according to technical analysis indicators.

Precigen (PGEN) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Precigen Inc	2.36%	10.17%	-9.09%	-41.7%	-70.59%
Biontech Se	-0.32%	51.19%	24.81%	-30.66%	288.02%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.55%	-28.89%	7.15%	74.63%
Vertex Pharmaceuticals Incorporated	16.87%	0.96%	13.03%	93.36%	95.94%
Alnylam Pharmaceuticals, Inc.	17.76%	5.53%	59.46%	84.7%	118.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Precigen Inc	NA	NA	NA	-0.46	-1.29	-0.42	NA	0.48
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Precigen Inc	Buy	$395.4M	-70.59%	NA	0.0%
Biontech Se	Buy	$29.7B	288.02%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	74.63%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	95.94%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	118.8%	NA	-15.86%

About Precigen

Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of UltraCAR-T to provide chimeric antigen receptor T cell therapies for cancer patients; AdenoVerse immunotherapy, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine antigen; and ActoBiotics for specific disease modification. It also develops programs based on the UltraCAR-T platform, including PRGN-3005 in Phase 1b clinical trial to treat advanced ovarian, fallopian tube, or primary peritoneal cancer; PRGN-3006 in Phase 1b trial for patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromes; and PRGN-3007 in Phase 1/1b trial for the treatment of advanced receptor tyrosine kinase-like orphan receptor 1-positive, hematologic, and solid tumors. In addition, the company is developing programs based on the AdenoVerse immunotherapy platform comprising PRGN-2009 in Phase 2 trial for patients with HPV-associated cancer; and PRGN-2012 in Phase ½ trial to treat recurrent respiratory papillomatosis, as well as AG019, which is based on the ActoBiotics platform and in Phase 1b/2a trial, to treat type 1 diabetes mellitus. Further, it provides UltraPorator, a proprietary electroporation device; and develops research models and services for healthcare research applications. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in February 2020. Precigen, Inc. was founded in 1998 and is headquartered in Germantown, Maryland.

Organization	Precigen
Employees	202
CEO	Mr. Randal J. Kirk J.D.
Industry	Health Technology

Management People of Precigen

Name	Title
Mr. Randal J. Kirk J.D.	Executive Chairman
Dr. Helen Sabzevari MPH, Ph.D.	President, CEO & Director
Mr. Harry Thomasian Jr.	Chief Financial Officer
Mr. Rutul R. Shah	Chief Operating Officer
Mr. Donald P. Lehr J.D., Ph.D.	Chief Legal Officer & Corporate Secretary
Mr. Jeffrey Thomas Perez J.D.	Senior Vice President of Intellectual Property Affairs
Mr. Steven Harasym	VP & Head of Investor Relations
Mr. Rob Russell	VP & Head of Human Resources
Dr. Douglas E. Brough Ph.D.	Senior VP & Head of Research
Dr. Bryan T. Butman Ph.D.	Senior VP & Head of CMC

Important FAQs about investing in PGEN Stock from India :

What is Precigen share price today?

Precigen share price today stands at $1.33, Open: $1.29 ; Previous Close: $1.30 ; High: $1.36 ; Low: $1.29 ; 52 Week High: $1.93 ; 52 Week Low: $0.65.

The stock opens at $1.29, after a previous close of $1.30. The stock reached a daily high of $1.36 and a low of $1.29, with a 52-week high of $1.93 and a 52-week low of $0.65.

Can Indians buy Precigen shares?

Yes, Indians can invest in the Precigen (PGEN) from India.

With INDmoney, you can buy Precigen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Precigen at zero transaction cost.

How can I buy Precigen shares from India?

It is very easy to buy Precigen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Precigen (PGEN) be purchased?

Yes, you can buy fractional shares of Precigen with INDmoney app.

What are the documents required to start investing in Precigen stocks?

To start investing in Precigen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.